In clinical work, in patients with diabetes and TVD, attention should also be paid to comprehensive strategies of these patients, such as improvement of lifestyle, lipoprotein-lowering therapy, antithrombotic therapy, sodium-dependent glucose transporters 2 inhibitors, Glucagon-like peptide-1 [27], and possible anti-inflammatory therapy [28]. This evidence concerns the gene GCG and diabetes mellitus.